Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)

Tibet Weixinkang Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	278.73	212.22	216.44	269.43	519.32	243.77
Trading Asset Securities	786.15	770	803	625.32	287	467.78
Cash & Short-Term Investments	1,065	982.22	1,019	894.75	806.32	711.55
Cash Growth	3.52%	-3.65%	13.94%	10.97%	13.32%	23.64%
Accounts Receivable	155.09	134.87	172.29	179.77	222.85	193.13
Other Receivables	2.2	2.17	1.93	2.2	2.14	1.22
Receivables	157.29	137.04	174.22	181.96	224.99	194.35
Inventory	63.44	59.82	41.96	38.34	32.54	22.68
Prepaid Expenses	-	0.07	2.62	1.73	1.68	2.14
Other Current Assets	103.38	109.77	77.14	83.12	73.43	78.44
Total Current Assets	1,389	1,289	1,315	1,200	1,139	1,009
Property, Plant & Equipment	410.59	416.46	380.25	361.21	333.73	324.14
Long-Term Investments	70.43	74.95	69.05	75.88	71.33	62.49
Other Intangible Assets	20.67	23.29	16.59	35.39	24.4	12.83
Long-Term Deferred Tax Assets	25.47	28.88	42.92	56.21	30.18	9.75
Long-Term Deferred Charges	38.65	15.73	16.91	26.36	41.52	73.35
Other Long-Term Assets	9.85	18.63	12.59	21.93	25.29	3.85
Total Assets	1,965	1,867	1,854	1,777	1,665	1,496

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	271.07	9.31	5.48	1.47	3.5	0.85
Accrued Expenses	11.2	255.69	314.28	269.95	284.17	271.98
Current Portion of Leases	-	3.97	2.89	3.86	2.31	2.47
Current Income Taxes Payable	18.13	2.06	0.66	3.83	6.78	4.3
Current Unearned Revenue	1.58	6.39	7.24	4.4	6.54	7.75
Other Current Liabilities	75.28	70.89	96.63	111.27	108.5	131.92
Total Current Liabilities	383.73	348.31	427.18	394.79	411.8	419.26
Long-Term Leases	4.57	7.23	2.38	3.82	3.48	2.35
Long-Term Unearned Revenue	5.52	4.17	7.05	3.84	5.25	6.7
Pension & Post-Retirement Benefits	-	20.27	28.86	-	-	-
Long-Term Deferred Tax Liabilities	9.71	10.5	2.78	3.46	1.17	-
Other Long-Term Liabilities	20.32	-	-	30.64	23.14	-
Total Liabilities	423.85	390.49	468.24	436.55	444.84	428.31

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	435.16	435.16	435.16	435.16	435.16	435.92
Additional Paid-In Capital	347.64	347.64	347.64	347.15	341.35	318.64
Retained Earnings	787.87	722.76	631.28	579.63	453.82	346.51
Treasury Stock	-30	-30	-30	-22.37	-23.8	-52.88
Comprehensive Income & Other	0.13	0.8	1.36	0.78	14.05	19.07
Total Common Equity	1,541	1,476	1,385	1,340	1,221	1,067
Shareholders' Equity	1,541	1,476	1,385	1,340	1,221	1,067
Total Liabilities & Equity	1,965	1,867	1,854	1,777	1,665	1,496

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	11.05	11.2	5.27	7.68	5.79	4.81
Net Cash (Debt)	1,054	971.02	1,014	887.07	800.53	706.73
Net Cash Growth	2.78%	-4.25%	14.33%	10.81%	13.27%	22.80%
Net Cash Per Share	2.45	2.25	2.35	2.07	1.85	1.69
Filing Date Shares Outstanding	439.12	432.33	432.33	435.16	435.16	435.92
Total Common Shares Outstanding	439.12	432.33	432.33	435.16	435.16	435.92
Working Capital	1,005	940.6	888.19	805.12	727.17	589.9
Book Value Per Share	3.51	3.41	3.20	3.08	2.80	2.45
Tangible Book Value	1,520	1,453	1,369	1,305	1,196	1,054
Tangible Book Value Per Share	3.46	3.36	3.17	3.00	2.75	2.42
Buildings	-	328.89	285.16	280.15	260.92	258.81
Machinery	-	339.93	297.15	274.57	236.19	215.29
Construction In Progress	-	21.45	37.98	15.19	17.11	-

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error